PhysicianZhengzhou People's Hospitalzhengzhou, Henan, China (People's Republic)
OC 24.5 - A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of a PEGylated-Recombinant Human Coagulation Factor VIII-Fc Fusion Protein in Patients With Severe Hemophilia A
Sunday, June 25, 202315:45 – 16:00 ET